Universal Display Corporation — FY2021 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2021. The filing is an annual Form 10-K rather than a standalone fourth-quarter filing; quarterly information is included only where disclosed. Universal Display develops and commercializes OLED technologies, phosphorescent OLED materials, intellectual property licenses, and related research services. Approximately 97% of revenue was generated outside North America, primarily from customers in South Korea and China.
Business Context
- Revenue is generated primarily from OLED material sales, royalty and license fees, and contract research services through Adesis.
- The company owns, exclusively licenses, or has the sole right to sublicense more than 5,500 issued and pending patents worldwide.
- Major customers include Samsung Display, LG Display, BOE, Tianma, Visionox, and CSOT. Three customers each represented more than 10% of consolidated revenue; the largest three represented approximately 84% in aggregate.
- Universal Display relies substantially on PPG Industries to manufacture OLED materials. The amended PPG agreement extends through December 31, 2024 and automatically renews thereafter unless terminated under the specified notice provisions.
Key Financial Metrics
Dollars are in millions unless otherwise stated.
| Metric | 2021 | 2020 | Change |
|---|---|---|---|
| Total revenue | $553.5 | $428.9 | +$124.7; +29% |
| Material sales | $318.6 | $229.7 | +$88.9; +39% |
| Royalty and license fees | $219.0 | $185.1 | +$34.0; +18% |
| Contract research services | $15.9 | $14.1 | +$1.8; +13% |
| Gross margin | $438.5 | $343.4 | +$95.1 |
| Gross margin percentage | 79% | 80% | Down approximately 1 percentage point |
| Operating income | $227.6 | $157.5 | +$70.1; +45% |
| Operating margin | 41.1% | 36.7% | Up approximately 4.4 points |
| Net income | $184.2 | $133.4 | +$50.8; +38% |
| Diluted EPS | $3.87 | $2.80 | +$1.07 |
| Cash dividends declared per share | $0.80 | $0.60 | +$0.20 |
| Cash flow from operations | $191.1 | $148.8 | +$42.3; +28% |
Liquidity, Capital Resources, and Balance Sheet
- At December 31, 2021, cash and cash equivalents were $312.0 million, short-term investments were $351.2 million, and long-term U.S. government bond investments were $159.6 million, totaling approximately $822.8 million of cash and investments.
- Working capital was $738.0 million, compared with $759.6 million at December 31, 2020.
- Cash used in investing activities was $457.8 million, primarily reflecting net investment purchases of $414.3 million and $43.2 million of property and equipment purchases.
- Cash used in financing activities was $51.4 million, including $37.9 million of dividends and $14.9 million of employee tax-withholding payments.
- The filing does not disclose conventional outstanding debt or borrowings. Total liabilities were $367.0 million, including $157.1 million of deferred revenue, $66.8 million of retirement plan liability, and $30.6 million of operating lease liabilities.
- Management expects existing cash, cash equivalents, and short-term investments to fund obligations for at least the next twelve months, although additional financing could be required for research, development, commercialization, patent activities, or working capital.
Material Changes Versus 2020
- Material sales recovered from pandemic-affected 2020 levels and increased 39%; unit material volume increased 34%. Green emitter sales increased 36% in volume and red emitter sales increased 31%.
- Royalty and license revenue increased 18%, primarily due to stronger customer sales of royalty-bearing OLED products.
- Research and development expense increased 19% to $99.7 million, driven by employee costs, OVJP development, contract research, and PPG development activity.
- Selling, general and administrative expense increased 31% to $80.4 million, partly due to Shannon, Ireland manufacturing pre-production costs and corporate expansion.
- Inventory increased to $134.2 million from $91.6 million. Inventory reserves increased to $3.6 million from $1.1 million due to excess inventory in certain products.
- Royalty and license expense declined to $0.7 million from $11.1 million, primarily due to lower royalties under amended academic license arrangements following patent expirations.
- The company established and began preparing a Shannon, Ireland manufacturing facility expected to double production capacity and diversify manufacturing. Operations were scheduled to commence by mid-2022.
- LG Display agreements were amended to extend their term through 2025. Agreements with Tianma were extended for an additional multi-year term, and Visionox entered into new five-year supply and license agreements with an affiliate.
Guidance, Outlook, Risks, and Unusual Items
- Management did not provide a specific revenue or earnings forecast in the filing. It expected COVID-19 to continue adversely affecting operations, revenue, net income, and cash flow at least through the first half of 2022.
- Key uncertainties include consumer demand for OLED products, customer production plans, supply-chain and logistics disruptions, trade restrictions, and the potential re-emergence of COVID-19.
- Revenue recognition for long-term OLED contracts depends on estimates of future material volumes, customer royalties, and contract consideration. KPMG identified the estimated per-unit fee for long-term OLED contracts as a critical audit matter.
- Customer concentration is substantial: the top customer represented 44% of 2021 revenue, the second represented 26%, and the third represented 14%. Loss, renegotiation, or reduced demand from a major customer could materially affect results.
- Fundamental PHOLED patents expired in certain jurisdictions between 2017 and 2020. The company maintains a large remaining portfolio but acknowledged that later patents may not provide equivalent competitive protection.
- The company is involved in an ongoing European Patent Office opposition concerning European Patent No. 1390962, relating to white phosphorescent OLED technology. Management believes significant claims should be upheld but cannot assure a favorable outcome.
- Patent infringement claims, challenges to licensed patents, customer indemnification obligations, and international intellectual-property disputes could result in substantial costs or reduced licensing and material revenue.
- PPG inventory purchase commitments were $25.7 million at year-end. The company also had up to $4.3 million of remaining obligations under its USC-sponsored research agreement.
- A Korean tax matter includes recognized long-term assets for potential withholding-tax refunds and related liabilities for potential U.S. tax obligations. The Korean Supreme Court dismissed the tax authority’s appeal regarding UDC Ireland’s beneficial ownership of certain royalty income in January 2022.
- Management and KPMG concluded that internal control over financial reporting was effective as of December 31, 2021. KPMG issued unqualified opinions on the consolidated financial statements and internal controls.
Important Facts for Investors to Verify
- Confirm the sustainability of 2021’s material-volume recovery and whether OLED demand remains strong after the pandemic-related comparison benefit.
- Monitor revenue concentration and contract renewals, extensions, minimum purchase obligations, royalty rates, and customer production plans.
- Assess the effect of PHOLED patent expirations and the company’s ability to enforce or commercialize its remaining patent portfolio.
- Track the timing, cost, capacity ramp, and customer qualification status of the Shannon, Ireland manufacturing facility.
- Review inventory growth, excess inventory reserves, customer order visibility, and the $29.1 million committed emitter-material backlog expected to ship within 90 days.
- Evaluate the impact of long-term contract estimates and cumulative catch-up adjustments on reported revenue and deferred revenue.
- Follow the European Patent No. 1390962 opposition and other intellectual-property proceedings.
- Verify the resolution and cash timing of Korean withholding-tax refund claims and related U.S. tax liabilities.
- Confirm the company’s stated liquidity position against planned capital expenditures, research and development spending, dividends, retirement benefits, leases, and potential future financing needs.